FOURTH TRI SERVICE TASK FORCE MEETING 29 OCT 90

File: 102596_sep96_decls4_0003.txt
Page: 0003
Total Pages: 5

Subject: FOURTH TRI SERVICE TASK FORCE  MEETING   29 OCT 90              

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003202

Folder Title: FOURTH TRI-SERVICE TASK FORCE PROJECT BADGER                                                    

Document Number:          1

Folder SEQ  #:          4






                                                    UNCLASSIFIED


         SGRD-ZC
         SUBJECT: Fourth Tri-Service Task Force (Project Badger)
         Meeting Mt

             d. (U) Dr. Johnson-Winegar contacted National Cancer
         Institute (NIH), Fort Detrick, Frederick, MD, concerning vaccine
         production. She was told that the 7500 liter fermenter was used
         to produce AIDS vaccines and chemotherapeutic drugs for
         investigational purposes. Furthermore, the contractor technical
         expert she spoke to, indicated that it would be "politically
         unacceptable" to shift production to vaccine for DOD. She asked
         to speak to a responsible individual at the NIH. She is
         expecting a call back within a week. COL Dangerfield will inform
         Dr. Collis of this situation.

             e. (U) MAJ Balady checked with Centers for Disease Control
         (CDC) to inquire who makes botulinum toxoid. He contacted Fort
         Dodge Laboratories and found that they are interested in working
         with us. Their facility is for veterinary production not human
         use (encl 5).

         5.       Status of production of anthrax vaccine. The following
         plan was agreed upon to address short term surge capability for
         anthrax vaccine.

             a. (U) CONUS and OCONUS companies identified to have
         capability to produce vaccines will be sent a request in writing
         by overnight mail on 29 October 1990 to determine interest in
         receiving a Request for Proposal (RFP).

             b. (U) Dr. Johnson-Winegar will prepare the written request
         by 26 October 1990. This will include generic information on the
         implications regarding vaccine production.

             C. (U) Companies will be asked to respond in writing within
         one week as to their interest or lack of interest in
         manufacturing vaccine.

             d. (U) The committee, in view of COL McCarty's results (see
ra 4a and 4b above), discussed the desirability of obtaining
         high level support for our attempt to expand production of
         vaccines. It was agreed that optimal benefit could be achieved
         by a generic endorsement to the companies queried by the
         Secretary of Defense. The committee also recognized that there
         is potential risk associated with such an endorsement in the
         absence of declared national emergency. COL Dangerfield will
         discuss with Dr. Collis the possibility of having the Secretary
         of Defense sign a personally addressed cover letter to each CEO
         accompanying the written request.

             e. (U) By 26 October 1990, MAJ Balady will provide the
         names and addresses of OCONUS companies identified to have

                                         2


                                    e               UNCLASSIFIED
                                             E*

Document 5 f:/Week-36/BX003202/FOURTH TRI-SERVICE TASK FORCE PROJECT BADGER/fourth tri service task force meeting 29 oct :1018961354305
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003202
Unit = OTSG
Parent Organization = HSC
Folder Title = FOURTH TRI-SERVICE TASK FORCE PROJECT BADGER
Folder Seq # = 4
Subject = FOURTH TRI SERVICE TASK FORCE MEETING 29 OCT
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 18-OCT-1996